UB Paderborn / Katalog / Suche / in CDI

Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion

Food and chemical toxicology, 2009-04, Vol.47 (4), p.760-768

2009

Link zum Volltext

Verfügbarkeit prüfen

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

Regulatory toxicology and pharmacology, 2003-12, Vol.38 (3), p.345-367

2003

Link zum Volltext

Verfügbarkeit prüfen

Kinetic Analysis of Furan Biotransformation by F-344 Rats in Vivo and in Vitro

Toxicology and applied pharmacology, 1993-12, Vol.123 (2), p.274-282

1993

Link zum Volltext

Verfügbarkeit prüfen

A physiologically based toxicokinetic model for the uptake and disposition of waterborne organic chemicals in fish

Toxicology and applied pharmacology, 1990-12, Vol.106 (3), p.433-447

1990

Link zum Volltext

Verfügbarkeit prüfen

Development of a physiologically based pharmacokinetic model for chloroform

Toxicology and applied pharmacology, 1990-05, Vol.103 (3), p.512-527

1990

Link zum Volltext

Verfügbarkeit prüfen

A Physiologically Based Dosimetry Description of Acrylonitrile and Cyanoethylene Oxide in the Rat

Toxicology and applied pharmacology, 1995-10, Vol.134 (2), p.185-194

1995

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: “Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion” [Food and Chemical Toxicology 47 (2009) 760–768]

Food and chemical toxicology, 2009-11, Vol.47 (11), p.2875-2875

2009

Link zum Volltext

Verfügbarkeit prüfen

Response to, “ Reaction on Gargas et al.: Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion”, by Hogervorst et al

Food and chemical toxicology, 2009-11, Vol.47 (11), p.2873-2874

2009

Link zum Volltext

Verfügbarkeit prüfen

Derivation of Noncancer Reference Values for Acrylonitrile

Risk analysis, 2008-10, Vol.28 (5), p.1375-1394

2008

Link zum Volltext

Verfügbarkeit prüfen

A Physiological Toxicokinetic Model for Exogenous and Endogenous Ethylene and Ethylene Oxide in Rat, Mouse, and Human: Formation of 2-Hydroxyethyl Adducts with Hemoglobin and DNA

Toxicology and applied pharmacology, 2000-05, Vol.165 (1), p.1-26

2000

Link zum Volltext

Verfügbarkeit prüfen

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

Regulatory toxicology and pharmacology, 2005-10, Vol.43 (1), p.85-103

2005

Link zum Volltext

Verfügbarkeit prüfen

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride

Toxicology and applied pharmacology, 1987-02, Vol.87 (2), p.185-205

1987

Link zum Volltext

Verfügbarkeit prüfen

Modeling Receptor-Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk Assessment

Risk analysis, 1993-02, Vol.13 (1), p.25-36

1993

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “pharmacokinetic modeling of 2,4-dichlorophenoxyacetic acid (2,4-d) in rat and in rabbit brain following single dose administration”

Toxicology letters, 1995-03, Vol.76 (2), p.185-185

1995

Link zum Volltext

Verfügbarkeit prüfen

Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane

Toxicology and applied pharmacology, 1990-08, Vol.105 (1), p.37-54

1990

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic modeling of 2, 4-dichlorophenoxyacetic acid (2,4-D) in rat and in rabbit brain following single dose administration

Toxicology letters, 1994-12, Vol.74 (3), p.189-201

1994

Link zum Volltext

Verfügbarkeit prüfen

Determination of Tissue Partition Coefficients for Volatile Tissue-Reactive Chemicals: Acrylonitrile and Its Metabolite 2-Cyanoethylene Oxide

Toxicology and applied pharmacology, 1994-09, Vol.128 (1), p.92-96

1994

Link zum Volltext

Verfügbarkeit prüfen

Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brain

Neurotoxicology and teratology, 1995-03, Vol.17 (2), p.111-120

1995

Link zum Volltext

Verfügbarkeit prüfen

A Physiologically Based Description of Ethylene Oxide Dosimetry in the Rat

Toxicology and industrial health, 1992-05, Vol.8 (3), p.121-140

1992

Link zum Volltext

Verfügbarkeit prüfen

Biological and physiological factors involved in disposition of dioxin and related compounds

Chemosphere (Oxford), 1992, Vol.25 (1), p.3-6

1992

Link zum Volltext

Verfügbarkeit prüfen

Relationship of hepatotoxicity and lethality with metabolic constants of BrCCl 3 in rats pretreated with chlordecone, phenobarbital and mirex

European journal of pharmacology, 1990, Vol.183 (4), p.1539-1539

1990

Link zum Volltext

Verfügbarkeit prüfen

Relationship of hepatotoxicity and lethality with metabolic constants of BrCCl3 in rats pretreated with chlordecone, phenobarbital and mirex

European journal of pharmacology, 1990-07, Vol.183 (4), p.1539

1990

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion

Assessing the dose-dependency of allometric scaling performance using physiologically based pharmacokinetic modeling

Kinetic Analysis of Furan Biotransformation by F-344 Rats in Vivo and in Vitro

A physiologically based toxicokinetic model for the uptake and disposition of waterborne organic chemicals in fish

Development of a physiologically based pharmacokinetic model for chloroform

A Physiologically Based Dosimetry Description of Acrylonitrile and Cyanoethylene Oxide in the Rat

Erratum to: “Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion” [Food and Chemical Toxicology 47 (2009) 760–768]

Response to, “ Reaction on Gargas et al.: Acrylamide: Consideration of species differences and nonlinear processes in estimating risk and safety for human ingestion”, by Hogervorst et al

Derivation of Noncancer Reference Values for Acrylonitrile

A Physiological Toxicokinetic Model for Exogenous and Endogenous Ethylene and Ethylene Oxide in Rat, Mouse, and Human: Formation of 2-Hydroxyethyl Adducts with Hemoglobin and DNA

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

Physiologically based pharmacokinetics and the risk assessment process for methylene chloride

Modeling Receptor-Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk Assessment

Corrigendum to “pharmacokinetic modeling of 2,4-dichlorophenoxyacetic acid (2,4-d) in rat and in rabbit brain following single dose administration”

Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane

Pharmacokinetic modeling of 2, 4-dichlorophenoxyacetic acid (2,4-D) in rat and in rabbit brain following single dose administration

Determination of Tissue Partition Coefficients for Volatile Tissue-Reactive Chemicals: Acrylonitrile and Its Metabolite 2-Cyanoethylene Oxide

Development of a physiologically based pharmacokinetic model for 2,4-dichlorophenoxyacetic acid dosimetry in discrete areas of the rabbit brain

A Physiologically Based Description of Ethylene Oxide Dosimetry in the Rat

Biological and physiological factors involved in disposition of dioxin and related compounds

Relationship of hepatotoxicity and lethality with metabolic constants of BrCCl 3 in rats pretreated with chlordecone, phenobarbital and mirex

Relationship of hepatotoxicity and lethality with metabolic constants of BrCCl3 in rats pretreated with chlordecone, phenobarbital and mirex

Suchergebnisse filtern